MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression

Long Noncoding RNAs (LncRNAs) have recently been identified as key regulator in tumor progression. The LncRNA MAFG-AS1 has been reported to facilitate the progression of multiple cancers, however, its role in prostate cancer is still unknown. Here, we reported that MAFG-AS1 was upregulated in prosta...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Peizhang Li, Yuanping Shi, Miaomiao Guo, Huan Xu, Ming Zhan, Zhong Wang, Yanbo Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-08-01
Subjects:	MAFG-AS1 lncRNAs prostate cancer prognosis tumor-microarray
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.856580/full